谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSFS) chemoimmunotherapy.

Benjamin Lerman,Yimei Li,Meaghan Granger,Thomas Cash,Arhanti Sadanand,Katherine Somers,Aeesha Ranavaya,Michelle Choe,Jennifer Foster,Daniel A. Morgenstern,Margarida Simao Rafael,Keri A. Streby, Rachel Zeno,Rajen Mody,Sahr Yazdani,Ami Vijay Desai,Margaret E Macy,Suzanne Shusterman,Sara Michele Federico,Rochelle Bagatell

Journal of Clinical Oncology（2022）

引用 0|浏览28
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要